Picture of Sourcebio International logo

SBI Sourcebio International Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Momentum

Relative Strength (%)
1m-5.74%
3m-0.1%
6m-18.26%
1yr-15.58%
Volume Change (%)
10d/3m-67.82%
Price vs... (%)
52w High-27.94%
50d MA-1.72%
200d MA-6.89%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)41.75
PEG Ratio (f)n/a
EPS Growth (f)-73.31%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value1.88
Price to Tang. Book2.38
Price to Free Cashflow3.53
Price to Sales0.98
EV to EBITDA2.94

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital34.76%
Return on Equity41.71%
Operating Margin22.84%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Sourcebio International EPS forecast chart

Profile Summary

SourceBio International plc is a provider of integrated laboratory services and products. The Company operates through four business segments: Infectious Disease Testing, Healthcare Diagnostics, Genomics and Stability Storage. Its Infectious Disease Testing segment offers COVID-19 antigen reverse transcription-polymerase chain reaction (RT-PCR) testing services to the national health service (NHS), private healthcare providers and private industry. Its Healthcare Diagnostics segment offers histopathology and clinical diagnostic services for the NHS and private healthcare across the United Kingdom and Ireland. Its Genomics segment offers deoxyribonucleic acid (DNA) sequencing services for pharmaceutical and biotechnology companies, academia, contract research organizations (CROs) and other research groups in the United Kingdom, Europe and North America. Its Stability Storage segment offers shelf-life testing services and equipment for pharmaceutical companies and others.

Directors

Last Annual
December 31st, 2021
Last Interim
December 31st, 2021
Incorporated
July 8th, 2016
Public Since
October 29th, 2020
No. of Employees
339
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
74,183,038

SBI Share Price Performance

Latest News for SBI

Upcoming Events for SBI

Half Year 2022 Sourcebio International PLC Earnings Release

Similar to SBI

Picture of Caretech Holdings logo

Caretech Holdings

gb flag iconLondon Stock Exchange

Picture of Chill Brands logo

Chill Brands

gb flag iconLondon Stock Exchange

Picture of CVS logo

CVS

gb flag iconLondon Stock Exchange

Picture of Integrated Diagnostics Holdings logo

Integrated Diagnostics Holdings

gb flag iconLondon Stock Exchange

Picture of IQ-AI logo

IQ-AI

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email